These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27353258)

  • 1. IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion.
    Voudouri K; Nikitovic D; Berdiaki A; Kletsas D; Karamanos NK; Tzanakakis GN
    Matrix Biol; 2016 Dec; 56():95-113. PubMed ID: 27353258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth.
    Casa AJ; Potter AS; Malik S; Lazard Z; Kuiatse I; Kim HT; Tsimelzon A; Creighton CJ; Hilsenbeck SG; Brown PH; Oesterreich S; Lee AV
    Breast Cancer Res Treat; 2012 Feb; 132(1):61-73. PubMed ID: 21541704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assay.
    Voudouri K; Nikitovic D; Berdiaki A; Tsiaoussis J; Kletsas D; Karamanos NK; Tzanakakis GN
    Data Brief; 2016 Dec; 9():568-572. PubMed ID: 27752527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
    Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
    Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.
    Felice DL; El-Shennawy L; Zhao S; Lantvit DL; Shen Q; Unterman TG; Swanson SM; Frasor J
    Endocrinology; 2013 Sep; 154(9):3219-27. PubMed ID: 23782942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.
    Azios NG; Dharmawardhane SF
    Neoplasia; 2005 Feb; 7(2):128-40. PubMed ID: 15802018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL; Fu R; Banko M
    Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I receptor-induced cell-cell adhesion of MCF-7 breast cancer cells requires the expression of junction protein ZO-1.
    Mauro L; Bartucci M; Morelli C; Andò S; Surmacz E
    J Biol Chem; 2001 Oct; 276(43):39892-7. PubMed ID: 11518717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Hu XF; DeLuise M; Zalcberg JR
    Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
    Luey BC; May FE
    Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between IGF-IR and ER induced by E2 and IGF-I.
    Yu Z; Gao W; Jiang E; Lu F; Zhang L; Shi Z; Wang X; Chen L; Lv T
    PLoS One; 2013; 8(5):e62642. PubMed ID: 23704881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules.
    Afratis NA; Bouris P; Skandalis SS; Multhaupt HA; Couchman JR; Theocharis AD; Karamanos NK
    Sci Rep; 2017 Jan; 7():40138. PubMed ID: 28079144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.